Aegerion Pharmaceuticals Competitors or Alternatives
Aegerion Pharmaceuticals's top competitors include Esperion, Ultragenyx and Hughston Clinic.
Aegerion Pharmaceuticals VS Esperion
Esperion is seen as one of Aegerion Pharmaceuticals's top competitors. Esperion was founded in 1998, and is headquartered in Ann Arbor, Michigan. Like Aegerion Pharmaceuticals, Esperion also competes in the Pharmaceuticals & Biotechnology industry. Esperion generates $167.7M more revenue vs. Aegerion Pharmaceuticals.
Aegerion Pharmaceuticals VS Ultragenyx
Ultragenyx is a top competitor of Aegerion Pharmaceuticals. Ultragenyx was founded in 2010, and its headquarters is in Novato, California. Like Aegerion Pharmaceuticals, Ultragenyx also competes in the Pharmaceuticals & Biotechnology field. Ultragenyx has 992 more employees than Aegerion Pharmaceuticals.
Aegerion Pharmaceuticals VS Hughston Clinic
Hughston Clinic is Aegerion Pharmaceuticals's #3 rival. Hughston Clinic was founded in Columbus, Georgia} in 1949. Like Aegerion Pharmaceuticals, Hughston Clinic also works within the Pharmaceuticals & Biotechnology industry. Compared to Aegerion Pharmaceuticals, Hughston Clinic generates $68.9M more revenue.
Looking for similar companies to Aegerion Pharmaceuticals?
Similar Companies
Companies in Cambridge with revenue in $100-500M range
See 46 companies
Pharmaceuticals companies in CambridgeSee 183 companies
Companies in Cambridge with employees in 250-500 rangeSee 131 companies
Biotechnology companies with revenue in $100-500M rangeSee 234 companies
Pharmaceuticals companies with revenue in $100-500M rangeSee 298 companies
Biotechnology companies with employees in 250-500 rangeSee 340 companies
Pharmaceuticals companies with employees in 250-500 rangeSee 347 companies
Pharmaceuticals companies in Greater BostonSee 500 companies
Pharmaceuticals companies in MassachusettsSee 516 companies
Trending News for Aegerion Pharmaceuticals and Aegerion Pharmaceuticals's Competitors
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., In...
BioMarin Pharmaceutical Inc. announced that the phase 3 PEGASUS trial evaluating Palynziq (pegvaliase─pqpz) met its primary efficacy endpoint, demonstr...
Positive results from the PURSUIT phase IIb trial for AstraZeneca's AZD0780 demonstrated a statistically significant low─density lipoprotein cholestero...
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemoly...
FDA Approves Amgen's Uplizna for Treatment of Immunoglobulin G4-Related Disease in Adult Patients - Website...
Regeneron stock touches 52-week low at $617.71 amid market shifts...
The European Medicines Agency asked for three clinical trials to be placed on hold until the exact cause of death of a US teenager, who suffered acute ...
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., I...
Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response rates and reduced disease ...
Frequently Asked Questions about Aegerion Pharmaceuticals
Who are Aegerion Pharmaceuticals's top competitors?
Aegerion Pharmaceuticals's top 3 competitors are Esperion, Ultragenyx, Hughston Clinic.Who is similar to Aegerion Pharmaceuticals?
Esperion is the most similar to Aegerion Pharmaceuticals. Ultragenyx and Hughston Clinic are also similar to Aegerion Pharmaceuticals.
Are Aegerion Pharmaceuticals and Esperion competitors?
Yes, Esperion is one of Aegerion Pharmaceuticals’s top competitors.